WHO recommends Eli Lilly, GSK-Vir's drugs, widening COVID-19 treatment pool
A World Health Organization (WHO) panel recommended use of two drugs by Eli Lilly, and GlaxoSmithKline and Vir Biotechnology for COVID-19 patients, adding treatment options as the fast-spreading Omicron variant renders many ineffective